Results 191 to 200 of about 7,432 (208)
Some of the next articles are maybe not open access.
Toch tamsulosine bij urinesteenlijden?
Huisarts en wetenschap, 2017De huisarts behandelt regelmatig patienten met een koliekaanval door een urinesteen. De recent vernieuwde NHG-Standaard Urinesteenlijden beveelt het gebruik van alfablokker tamsulosine niet meer aan. Maar een nieuwe systematische review concludeert dat alfablokkers wel zorgen voor een snellere steenpassage en minder pijn.
openaire +2 more sources
Chiral separation of tamsulosin by capillary electrophoresis
Journal of Pharmaceutical and Biomedical Analysis, 2005Enantiomers of (+/-) 5-[2 (R,S)-{[2-(o-ethoxyphenoxy) ethyl] amino} propyl]-2-methoxy-benzenesulfonamide (tamsulosin, drug frequently used in the treatment of prostate diseases) were separated by capillary electrophoresis (CE). An acidic background electrolyte (BGE) with sulfated-beta-cyclodextrin (S-beta-CD) was used to create a chiral separation ...
Jan Petr +5 more
openaire +3 more sources
Tamsulosin for the Treatment of Benign Prostatic Hypertrophy
The Annals of Pharmacotherapy, 2000OBJECTIVE: To review the information necessary to assess the efficacy and safety of tamsulosin compared with other adrenergic antagonists for treatment of symptomatic benign prostatic hyperplasia. DATA SOURCES: A search was conducted of Cumulated Index Medicus, January 1993–August 1999, which was restricted to human trials and English-language journals.
openaire +2 more sources
Tamsulosin and the Intraoperative Floppy Iris Syndrome
JAMA, 2009THE INTRAOPERATIVE FLOPPY IRIS SYNDROME (IFIS) was first described by Chang and Campbell in 2005. These authors and others observed that there was a tendency for poor pupillary dilation and the intraoperative triad of the billowing of a flaccid iris, the propensity for iris prolapse, and progressive intraoperative pupillary constriction. In the current
openaire +3 more sources
Efficacy and safety of tamsulosin in the treatment of urological diseases
Expert Opinion on Pharmacotherapy, 2004The alpha(1)-adrenoceptor antagonist, tamsulosin, is selective for alpha(1A)- and alpha(1D)- over alpha(1B)-adrenoceptors. Both placebo-controlled and comparative studies with other agents have demonstrated tamsulosin to be an effective treatment for patients with lower urinary symptoms suggestive of benign prostatic hyperplasia.
Martin C. Michel +1 more
openaire +3 more sources
Tamsulosin and Iris Pigmentation
Ophthalmology, 2010Julio González Martín-Moro +2 more
openaire +3 more sources
Efficacy and safety of tamsulosin OCAS
BJU International, 2006The efficacy and safety of a new tablet formulation of tamsulosin (the oral‐controlled absorption system: OCAS®) have been assessed in several clinical trials. In a phase IIb and a phase IIIa trial, the appropriate dose of the tamsulosin tablet for clinical practice was determined.
openaire +2 more sources
Variations in intake of tamsulosin
Journal of Cataract and Refractive Surgery, 2007Shyamanga Borooah, Vikas Chadha
openaire +3 more sources
Worldwide experience with alfuzosin and tamsulosin
Urology, 2001Michael T. Flannery +2 more
openaire +3 more sources